Job Openings

Job Openings

There are no open positions at this time. If you would like to submit a resume for future consideration, you may send it to us via email.  

News

  • News Release: January 31, 2018
    First Triojection cases in Germany were recently completed by Prof. Dr. Thomas Vogl MD.
  • News Release: November 14, 2017
    Minimus Spine signs first European Distribution Agreement with MOSS S.p.A. and completes initial stocking order.
  • News Release: August 18, 2017
    Dr. Alexis Kelekis to present update on European study at CIRSE 2017.
  • News Release: February 20, 2017
    Jeffrey R. Binder appointed to Minimus Spine's board of directors.
  • News Release: November 14, 2016
    Minimus Spine enrolls 30th patient in European study comparing Triojection® to discectomy.
  • News Release: September 15, 2015
    Minimus Spine initiates European study comparing Triojection® to discectomy.
  • News Release: March 6, 2015
    Minimus Spine announces another key Triojection® patent issued by USPTO.
  • News Release: December 9, 2014
    Minimus Spine announces first ever cases with Triojection® System.
  • News Release: August 4, 2014
    Minimus Spine secures ISO 13485 and EC Certification for Triojection™ System.
  • News Release: December 10, 2013
    Minimus Spine closes deal with Texas for $1.75M.
  • News Release: October 8, 2013
    Minimus Spine secures two new patents from USPTO.
  • News Release: November 5, 2012
    Minimus Spine Raises Over $500k in Angel Financing for Triojection and Appoints Wes Johnson to Board of Directors.
  • News Release: August 29, 2011
    Minimus Spine Receives Notice of Allowance for its Syringe Designed to Produce Ozone for Spinal Injection.
  • News Release: October 1, 2009
    Minimus Spine Granted its First US Patent for Spinal Ozone
  • Read a 2008 interview with David Hooper of Minimus Spine from Austin Entrepreneur